J Biol Chem, Vol. 274, Issue 43, 30402-30409, October 22, 1999
Conservation and Divergence of the Yeast and Mammalian Unfolded
Protein Response
ACTIVATION OF SPECIFIC MAMMALIAN ENDOPLASMIC RETICULUM STRESS
ELEMENT OF THE grp78/BiP PROMOTER BY YEAST Hac1*
Dolly M.
Foti
,
Ajith
Welihinda§,
Randal J.
Kaufman§, and
Amy
S.
Lee
¶
From the
Department of Biochemistry and Molecular
Biology and the University of Southern California/Norris Comprehensive
Cancer Center, University of Southern California School of Medicine,
Los Angeles, California 90089 and the § Department of
Biological Chemistry, and the Howard Hughes Medical Institute,
University of Michigan Medical School, Ann Arbor, Michigan 48109
 |
ABSTRACT |
Yeast Hac1 (yHac1), the transcription factor that
binds and activates the unfolded protein response element of
endoplasmic reticulum (ER)-chaperone gene promoters, only accumulates
in stressed cells after an unconventional splicesosome-free mRNA
processing step and escape from translation block. In determining
whether the novel regulatory mechanisms for yHac1 are conserved in
mammalian cells, we discovered a unique unfolded protein response
element-like sequence within the endoplasmic reticulum stress element
163, one of the three ER stress elements recently identified in the rat
grp78 promoter. The unspliced form of yHac1 is stably
expressed in nonstressed mammalian cells and is as active as the
spliced form in stimulating the promoter activities of grp
genes. Further, the yHac1 mRNA is not processed in
response to ER stress in mammalian cells. We identified a CCAGC motif
as the yHac1 binding site, which is contained within a YY1 binding site
previously shown to be important for mammalian UPR. Dissection of the
yHac1 and the YY1 binding sites uncovered specific contact points for
an activator protein predicted to be the mammalian homolog of yHac1, the activity of which can be stimulated by YY1. A model of the conserved and unique features of the yeast and mammalian unfolded protein response transcription machinery is proposed.
 |
INTRODUCTION |
The endoplasmic reticulum
(ER)1 is an essential
organelle for cell viability. In addition to serving as a major
intracellular store for calcium and the production site for lipids and
sterols, ER is the cellular organelle for the synthesis, assembly, and glycosylation of proteins that are destined for secretion or transport to the cell surface. Perturbations of ER result in stress signaling from the ER to the nucleus, leading to the activation of specific sets
of genes (1, 2). Conserved from yeast to human is a mechanism referred
to as the unfolded protein response (UPR) (3, 4). In
Saccharomyces cerevisiae, several key components of the UPR
have been identified through genetic analysis and biochemical characterizations. Thus, the yeast UPR is mediated by a novel signaling
pathway that requires ER stress-inducible splicing of the primary
transcript of Hac1, also referred to as Ern4p (5, 6). The open reading
frame of the Hac1 gene encodes a protein of 230 amino acids
(aa), whereas the active transcription factor is a 238-aa protein. In
nonstressed yeast cells, the unspliced Hac1 mRNA is prevented from
translation into the 230-aa protein by the presence of a translation
attenuator in a 252-bp intron (6, 7). Upon induction of the UPR,
unconventional splicing mediated by Ire1p results in the elimination of
the intronic sequence, which contains the codons encoding the last 10 aa of the 230-aa Hac1 and part of the 3'-untranslated region. Although
the last 10 aa of 230-aa Hac1 is deleted through this process, the
newly spliced Hac1 mRNA contains an additional exon of 18 aa,
resulting in the translation of the 238-aa Hac1. Finally, in yeast
cells, 230-aa Hac1 and 238-aa Hac1 produced from exogenous vectors are stable and can bind UPRE; however, the transactivating activity of the
230-aa Hac1 is lower than that of the 238-aa Hac1 (6).
The recognition sequence for yHac1 is a 22-bp sequence referred to as
the unfolded protein response element (UPRE), which is found in the ER
stress-inducible promoter of yeast ER resident protein genes such as
KAR2 and PDI1. The yeast UPRE contains an imperfect palindrome with a spacer of one nucleotide (CAGcGTG). The
steric configuration of the UPRE appears to be critical because insertion or deletion of a single nucleotide within the spacer region
results in the complete loss of its ability to mediate the UPR (8). One
of the best characterized ER stress-inducible genes is
grp78, the mammalian homolog of KAR2 (1).
Contrary to yeast, the rat grp78 promoter is functionally
redundant and contains three ER stress elements termed ERSE (9, 10).
The consensus ERSE derived from comparison of a variety of ER
stress-inducible mammalian promoters consists of a tripartite structure
CCAAT(N9)CCACG, with N9
being a strikingly GC-rich region of 9-bp. The ERSE physically and
functionally interacts with multiple mammalian transcription factors
including that of YY1, Y-box proteins, YB-1, dbpA, NF-Y/CBF, and a
newly discovered ER stress-inducible complex termed ERSF (10-13).
Although the various ERSEs share similar sequence motifs and can
independently confer the mammalian ER stress response to heterologous
promoters (10, 14, 15), there are subtle differences that are
evolutionarily conserved and could have functional implications for
their regulation. For example, ERSE-163 contained within the
grp78 core (16) bears the sequence CCAGC instead of the
consensus CCACG found in ERSE-98 contained within the C1 element, which
is most proximal to the TATA element (10). The CCAGC sequence within
ERSE-163 of the grp78 core is of particular significance
because in vivo genomic footprinting revealed that it is the
major region on the grp78 promoter where ER stress-induced factor occupancy changes are detected (16), correlating with its
functional importance based on 5' deletion analysis (17).
We have previously identified the multifunctional transcription factor
YY1 as a major DNA-binding protein to ERSE-163 (12). The unconventional
YY1 binding site encompasses the CCAGC motif and its flanking sequence.
In co-transfection studies using NIH3T3 cells, YY1 had little effect on
the basal expression of the grp78 promoter but specifically
enhanced induction of the grp78 promoter in a DNA
binding-dependent manner by a variety of ER stress
conditions. Consistent with divergent transcriptional regulatory
mechanisms for the different ERSEs, YY1 stimulates the grp78
core but the same effect was not observed for the C1 element containing
ERSE-98 (10). Interestingly, YY1 has not been found in yeast, and the mammalian homolog of Hac1 has not yet been identified.
Based on the similarity between the mammalian and yeast UPR, we seek to
determine whether the unique regulatory mechanisms for Hac1 discovered
in S. cerevisiae are conserved in mammalian cells. Our
studies revealed several novel observations suggesting both
conservation and divergence of the mammalian and yeast UPR. We
discovered that among the three ERSEs of the rat grp78
promoter, only ERSE-163 contained within the grp78 core
shares sequence identity with the partial palindromic sequence of the
yeast UPRE. This is the only ERSE that can bind and can be
transactivated by yHac1. We further showed that yHac1
mRNA is not processed in response to ER stress in mammalian cells.
Both the unspliced and spliced form of yHac1 can be stably expressed in
nonstressed mammalian cells and exhibit similar stimulatory activity
toward the grp78 promoter. The grp94 promoter,
which shares sequence identity with the 78core (17), is also strongly
activated by yHac1. The binding site of yHac1 is contained within the
YY1 binding site, and binding of yHac1 to ERSE-163 is strictly
dependent on the sequence integrity of the CCAGC motif. Through base
mutations that selectively destroy either the yHac1 or YY1 binding
site, we defined critical contact points for an activator protein
predicted to be the mammalian homolog of yHac1, the activity of which
can be stimulated by YY1. Based on these observations, we propose a
model of the conserved and unique features of the yeast and mammalian
UPR transcription machinery.
 |
MATERIALS AND METHODS |
Plasmid Constructions--
To construct the mammalian expression
vector for 230-aa Hac1, Hac1 was released from the glutathione
S-transferase-Hac1 construct by BamHI and
EcoRI digestion, and the 700-bp fragment was subcloned into
the same sites of the mammalian expression vector pMCX-PL1 (gift of R. Buettner, University of Regensburg, Germany) to generate pMCX-Hac1. The
HA epitope-tagged, spliced version of Hac1
(HAC1i) was constructed by PCR amplification
using pJC835 (5) as template DNA and primers N2 and C2. The PCR product
was digested with XbaI and subcloned into the
XbaI site of pED (18). Overlap extension PCR was performed
to construct HA epitope-tagged, unspliced HAC1
(HAC1u). This was amplified as two fragments
with primers N2, C3 and N3, C2 using pJS835 (5), and yeast genomic DNA
as templates, respectively. The sequences for the new primers are: N2,
acatctagaaaccgccaccatggaaatgact; N3, aaatctagaagagtcgacgacgctacctg; C2,
aaaaaatctagataccctcttgcgattgtcttc; and C3, caaagggtagactgtttcccgc. The
PCR products were mixed and reamplified with primers N1 and C1,
digested with XbaI, and subcloned into the XbaI
site of pED.
The construction of the 78core(M5)CAT is identical to the construction
of 78core/CAT [(formerly referred to as (
169/
135)MCAT), which has
been described (14), with the exception of a single base mutation from
G to T at
146 as shown in Fig. 7. For the construction of
154(M6)CAT, PCR-directed site mutagenesis was used to create the base
mutations at
140,
143, and
144 as shown in Fig. 8. All mutations
were verified by DNA sequencing. Expression vectors CMV-YY1 and the
DNA-binding deletion mutant CMV-YY1
were gifts from Y. Shi (Harvard
Medical School), and their construction has been described (19).
Transfection Conditions--
NIH3T3 cells, a murine embryonic
fibroblast cell line, was maintained in high glucose Dulbecco's
modified Eagle's medium containing 10% fetal bovine serum at
35 °C. The cells were transfected using either the calcium phosphate
method as described previously (12) or with SuperFect reagent (Qiagen).
The grp78 promoter/CAT fusion genes
154CAT, 78coreCAT
(formerly referred to as (
169/
135)MCAT), and 78C1CAT (formerly
referred to as (
109/
74)MCAT) have been described (14). The
grp94 promoter/CAT fusion gene
357CAT has been described
(20). The construction of the 78core(M5)CAT and the
154(M6)CAT was
described above. For the calcium phosphate transfections, NIH3T3 cells,
seeded in duplicate sets in 10-cm-diameter dishes, were co-transfected
with 5 µg of the CAT reporter gene, 5 µg of the expression vector
for Hac1, or the vector alone. 5 µg of the pSV40
-galactosidase
plasmid were also co-transfected to monitor efficiency of transfection.
Each transfection experiment was repeated at least three times. For
transfections using SuperFect, NIH3T3 cells were seeded in duplicate in
10-cm-diameter plates, treated for 2 h with a mixture of
DNA/SuperFect 1:5 containing 5 µg of CAT reporter gene, 2 µg of
Hac1 and/or YY1 expression plasmid, 1 µg of pSV40
-galactosidase,
and pMCX-L1 in the amount requested to keep the total DNA concentration
to 10 µg/plate. For stress induction, 24 h after transfection
the cells were treated with 1.5 µg/ml of tunicamycin or 300 nM thapsigargin (Tg) for 16 h prior to harvesting.
Preparation of the cell lysates for CAT assays and the quantitation of
the CAT assays have been described (12). Each transfection was repeated
three to five times. COS-1 cells were transiently transfected with pED,
pED-HA-Haci, pED-HA-HACu, pED-hIRE1 (21), and
pED-hIRE1 K599A (21) using a calcium phosphate procedure (22). At
48 h post-transfection, cells were treated with tunicamycin (10 µg/ml) for 6 h and harvested in Nonidet P-40 lysis buffer. Cell
extracts were analyzed by SDS-polyacrylamide gel electrophoresis and
Western blotting.
In Vitro Transcription and Translation--
In vitro
translated Hac1 and YY1 were obtained with the TNT coupled reticulocyte
system (Promega, Madison, WI) according to the manufacturer's
instructions. For this purpose, pCMX-Hac1 was linearized with
XbaI, whereas pCMV-YY1 (gift of Y. Shi, Harvard Medical
School) was used undigested.
Gel Mobility Shift Assays--
For EMSAs with in
vitro translated proteins, 2 µl of the TNT in vitro
coupled transcription/translation reaction mixture were used in the
binding reactions. In some reactions, 5 µl of cell lysate from
transfected cells were used. Hac1 binding conditions were accomplished
in 20 µl of 20 mM Hepes, 50 mM KCl, 2.5 mM EDTA, 0.5 mM dithiothreitol, and 1 µg of
poly(dI·dC). YY1 binding conditions have been previously described
(12). Samples were preincubated for 5-10 min at room temperature in
binding buffer, to which competitor oligos were added whenever
specified. After addition of 1-5 ng of probe, the reactions were
further incubated at room temperature for 15 min and loaded onto a
nondenaturing 4% polyacrylamide gel containing 2.5% glycerol.
Western Blotting--
Western blotting was performed by standard
procedures (23). The blot was sequentially probed with anti-influenza
HA epitope (Roche Molecular Biochemicals Corp.) and anti-Hac1 (raised
against the last 10 aa of processed yHac1 and kindly provided by P. Walter (5)) primary antibodies and horseradish peroxidase-conjugated goat anti-mouse secondary antibodies. Bands were visualized using the
ECL kit (Amersham Pharmacia Biotech).
 |
RESULTS |
Unique Occurrence of a UPRE-like Sequence within the Conserved
grp78 Core--
The rat grp78 promoter contains three ERSEs
(ERSE-98, ERSE-131, and ERSE-163) upstream of the TATA element (Fig.
1A). In slight variation to
the consensus ERSE sequence of CCAAT(N9)CCACG, ERSE-163 contains a CGAAT motif separated by 9-bp from a CCAGC motif. Further, in contrast to other ERSEs, ERSE-163 contained within the
grp78 core region spanning
170 to
135 exhibits two
distinct features, suggesting its functional importance in the in
vivo regulation of the endogenous grp78 promoter.
First, in vivo genomic footprinting revealed that
stress-inducible footprint changes occurred primarily within the
GGCCAGCTTG sequence of ERSE-163 (Fig. 1A). Second, with the
exception of 2-bp, this sequence is identical to the core of the
yeast UPRE sequence GGACAGCGTG, which is the DNA-binding site for
yHac1. The binding of Hac1 to the UPRE is strictly dependent on the
sequence integrity of the UPRE, because insertion of only 1 bp within
the UPRE as in the case of UPREm (Fig. 1A)
completely eliminates Hac1 binding. Scanning of the rat 78 promoter
sequence reveals no other substantial match with the yeast UPRE, and no
Hac1 binding was detectable with the other ERSEs (data not shown).

View larger version (39K):
[in this window]
[in a new window]
|
Fig. 1.
Identification of a UPRE-like site within the
grp78 core sequence. A, localization
of the ERSEs in the rat grp78 promoter and comparison of the
grp78 core sequence, the yeast UPRE, as well as the one
nucleotide insertion mutant UPREm, that were used in EMSAs
to investigate binding ability and specificity of yHac1.
Boxed nucleotides in the 78core sequence represent the two
conserved motifs separated by 9-bp contained within the consensus ERSE
(10). Open stars and arrows denote inducible
changes detected by in vivo genomic footprinting (16). In
the UPRE and UPREm sequences, the yHac1 binding site is
boxed, with the single base addition within
UPREm indicated by an italicized lowercase
letter. Other lowercase letters represent linker
sequences. Bold letters indicate the nucleotides identical
between 78core and the UPRE. B, schematic drawing of the
expression vector used for in vitro
transcription/translation of Hac1 (230 aa), as well as for
co-transfection experiments in NIH3T3 cells. The relative locations of
the ATG translation initiation codon, the basic (b) and the
leucine zipper (LLV) domains within the BamHI
(B) and EcoRI (E) fragment are
indicated. C, lysates from cells transfected with pCMX-Hac1
(230 aa) were tested by EMSA to detect UPRE-specific binding activity
versus control cells, which were transfected with the empty
vector. 5 µl of the cell lysate were preincubated in binding buffer
containing no competitor (lanes 1 and 4), 50-fold
molar excess of UPRE (lanes 2 and 5), or
UPREm (lanes 3 and 6) as competitor,
and binding reactions were further carried out with 100,000 cpm of
labeled UPRE/sample.
|
|
Functional Conservation of yHac1 as a Transcription Regulator of
the Mammalian grp78 Promoter--
With the identification of a
UPRE-like sequence within the grp78 core, we next tested
whether yHac1 can be stably expressed in mammalian cells and what
effect, if any, it has on the grp78 promoter activity under
stressed and nonstressed conditions. First, 230-aa Hac1 was subcloned
into a mammalian expression vector (Fig. 1B) and transiently
transfected into NIH3T3 cells. To test for the ability of the mammalian
cells to stably express yHac1, cell lysates were prepared from cells
either transfected with the empty vector or the Hac1 expression vector.
The cell extracts were used in EMSAs with the UPRE as probe (Fig.
1C). In the control cells transfected with empty vector, no
UPRE binding activity was detected. In cells transfected with the Hac1
expression vector, a strong UPRE binding complex was readily detected.
The specificity of UPRE binding was confirmed by efficient competition
with the wild type but not the mutated UPRE.
To test the effect of overexpression of 230-aa Hac1 on grp78
promoter activity, the expression vector for Hac1 was co-transfected into NIH3T3 cells with
154CAT, which retains all the ER
stress-inducible properties of the rat grp78 promoter (14).
As expected, in cells transfected with the empty vector, an 8-fold
induction of the promoter activity was detected with the ER stress
inducer Tg, which depletes the ER calcium store and tunicamycin, which
blocks protein glycosylation (Fig. 2). In
nonstressed cells, co-transfection of 230-aa Hac1 resulted in a 7-fold
induction of the basal grp78 promoter activity. Upon
treatment of the cells with Tg or tunicamycin, the overall promoter
activity further increased to about 25-fold (Fig. 2). Similarly, the
grp94 promoter, which shares sequence identity with the
78core (17), was also strongly induced by yHac1. These results indicate
that yeast 230-aa Hac1, when overexpressed in mammalian cells, is
highly functional as a transcription factor and acts as a potent
stimulator of the grp promoter activities in both
nonstressed and stressed cells.

View larger version (55K):
[in this window]
[in a new window]
|
Fig. 2.
Effect of yHac1 (230 aa) on the basal and
stress-induced transcription of the grp promoters. NIH3T3 cells, in duplicate set of plates, were
cotransfected with either 5 µg of the reporter plasmid
grp78( 154CAT) or grp94( 357CAT) and the same
amount of the expression vector for yHac1 (pMCX-L-Hac1) or vector alone
(pMCX-L1). 5 µg of SV40 Gal were also cotransfected to monitor
efficiency of transfection. 24 h after transfection the cells were
either left untreated or treated with 300 nM Tg or 1.5 µg/ml of tunicamycin (Tuni) for 16 h as indicated on
top. The promoter activity was determined by the percentage
of conversion of [14C]chloramphenicol (CM) to
its acetylated forms (1-Ac and 3-Ac).
A, representative autoradiograph of CAT assay results is
shown, with its quantitation shown directly below in B. The
fold induction was calculated by dividing the percentage of
[14C]chloramphenicol conversion under Tg- or
tunicamycin-induced conditions by that under control conditions. The
standard deviation is shown.
|
|
Stable Expression of Unspliced yHac1 in Mammalian
Cells--
Because yHac1 can exist as a 230-aa protein if the
translation is terminated at the first termination codon or as a 238-aa protein if the primary transcript has undergone splicing, we compared the potency of the various forms of yHac1 to enhance grp78
promoter activity. Prior to these experiments, it is of interest to
determine whether transfection of the intact yHac1 gene into
nonstressed mammalian cells would result in translation block as
observed in S. cerevisiae or whether translation would
proceed resulting in a 230-aa protein that could be stably expressed.
To facilitate detection of the yHac1, the HA epitope was inserted into
the amino end of the Hac1 coding sequence, which was
subcloned into the mammalian expression vector, pED (Fig.
3A). Similarly, an HA-tagged Hac1 gene encoding the induced form of 238-aa Hac1 was also
constructed. Upon transient transfection into COS cells, yHac1 protein
expression level was determined by Western blotting with antibodies
against the HA-epitope (Fig. 3B). The unusual
electrophoretic mobility of the 230-aa Hac1 and 238-aa Hac1 was in
agreement with that previously reported for Hac1 (6). As expected,
238-aa Hac1 was produced from the vector expressing the induced form of
Hac1. However, with the expression vector containing the
unspliced form of the Hac1 gene, predominantly 230-aa Hac1
was produced. These results revealed that in contrast to S. cerevisiae, the unspliced form of yHac1 can be translated and
stably expressed in nonstressed mammalian cells.

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 3.
Expression profile of noninduced and induced
forms of yHac1. A, schematic drawing of the HA-tagged
forms of yHac1. The uninduced form (Hac1u) or the induced
form (Haci) were subcloned into the expression vector pED
and transfected into COS cells. B, lysates from cells
transfected with the empty vector (V) or the two different
forms of yHac1 as indicated on top were subjected to Western
blot analysis using the HA antibody. C, lysates from mock
transfected cells (lane 1), nonstressed cells expressing the
two forms of Hac1 (lanes 2 and 3), cells
transfected with Hac1u and treated with tunicamycin
(lane 4), and cells co-expressing the human Ire1 (lane
5) or co-expressing the K599A mutant form of human Ire1
(lane 6) were analyzed by Western blotting using anti-HA
antibody and an anti-yHac1 antibody that only recognizes the spliced
form of yHac1. Migration of the 230-aa (asterisk) and 238-aa
(arrow) forms of yHac1 is indicated. The 238-aa form of Hac1
migrates faster upon SDS-polyacrylamide gel electrophoresis, likely
because of charge differences in the C-terminal portion of the
protein.
|
|
To investigate further whether yHac1 mRNA is processed
to produce the 238-aa Hac1 in response to ER stress in mammalian cells, COS-1 cells transiently transfected with the expression vectors for
HAC1I and HAC1u were
treated with tunicamycin and cell lysates prepared for analysis by
Western blotting. In contrast to the anti-HA antibody, which detected
the 238- and 230-aa forms in the HAC1I and
HAC1u transfected cells, respectively, probing
the same blot with anti-Hac1 antibody that specifically recognizes
238-aa yHac1 indicated that the 238-aa form was present only in cells
transfected with HAC1i but not with
HAC1u (Fig. 3C, lanes 2 and 3). Both tunicamycin treatment and co-transfection with
the human Ire1 (21) failed to produce the 238-aa form in the
HAC1u transfectants (Fig. 3C,
lanes 4 and 5). The inclusion of the K599A mutant
form of Ire1 (21) also showed no effect (Fig. 3C, lane 6). Further, reverse transcription-PCR failed to detect
the predicted spliced form of Hac1 mRNA (data not
shown). These combined results show that yHac1 mRNA is
not processed in COS-1 cells.
Having established that yHac1 encoded by various DNA templates can be
stably expressed in mammalian cells, their effect on the
154CAT
reporter gene in both control and Tg-treated NIH3T3 cells were
determined in co-transfection experiments. Our results showed that all
three forms of yHac1 (230-aa Hac1, HA-tagged 230-aa Hac1 from unspliced
template, and HA-tagged 238-aa Hac1 from spliced template) were able to
stimulate the basal grp78 promoter activity by about 7-fold,
after Tg induction, up to an overall promoter activity of 20-30-fold,
as compared with the 8-fold induction observed in Tg-treated
transfection with the empty vector (Fig. 4). Collectively, these experiments
suggest that a Hac1-like activating activity is rate-limiting in
mammalian cells toward transcription induction of the grp78
promoter, and this activity can be mimicked by overexpression of the
yHac1, either in the form of a 230- or 238-aa protein.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 4.
Various forms of yHac1 exert comparable
stimulation on the rat grp78 promoter. The yHac1
was expressed in co-transfection experiments in NIH3T3 cells using
either of three different constructs encoding the 230-aa version
(pMCX-Hac1-230aa), the spliced version of 238 aa
(pED-HA-Hac1i), or the unspliced version
(pED-HA-Hac1u) with 154 CAT as the reporter gene. The
fold induction of the promoter activity by the various forms of yHac1
under control ( ) or Tg-treated conditions (+) are graphed. The
standard deviation is shown.
|
|
Binding of yHac1 to ERSE-163 within the grp78 Core
Sequence--
With the identification of a UPRE-like site within the
rat grp78 core sequence, we first determined whether yHac1
can bind to the grp78 promoter sequence. For this purpose,
230-aa Hac1 was translated in vitro and used in EMSAs with
either the grp78 core sequence or the yeast UPRE as
radiolabeled probes (Fig. 5). Yeast Hac1
was able to bind to the grp78 core sequence, and its binding
to the UPRE was stronger. The binding activity to the 78core sequence
is attributed to yHac1 because it could be specifically competed by
molar excess of the wild type but not the mutant UPRE. Further, as
reported for yHac1 (8), this binding activity was enhanced by the
addition of 10 mM magnesium in the binding reaction (data
not shown).

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 5.
Binding of yHac1 to the grp78 core. 1.5 µl of in vitro translated yHac1 were
used in EMSAs with labeled 78core as probe (lanes 1-3). The
complex formed as shown in lane 1 was competed by a 10-fold
molar excess of unlabeled UPRE (lane 2) or UPREm
(lane 3). In lane 4, labeled UPRE was used as
probe in the absence of competitor.
|
|
To map more precisely the critical DNA contact points for yHac1 within
the 78core, the ability of a set of mutants of the 78core (M1 through
M4) with clustered 4-bp mutations around the UPRE-like site to bind
in vitro translated yHac1 was examined (Fig.
6A). The sequence of the
mutated bases is shown in Fig. 6B. Each of the core
sequences was individually labeled and used as probes in EMSAs. The
wild-type core sequence and the UPRE were included as positive
controls. As expected, the strongest binding of yHac1 was observed with
the UPRE probe. Among the 78core sequence, yHac1 bound with similar
affinity to M3 and M4 as with the wild-type sequence. In contrast,
binding of Hac1 to M2 was severely diminished. In M2, the CAGC motif of
ERSE-163, which shares complete sequence identity with the UPRE was
mutated to ACTA. The result obtained for M3, although unexpected,
suggested that the exact TTGG sequence motif at 3' half of the
UPRE-like sequence may not be critical for yHac1 binding. For M4, which
lies outside the boundary of the UPRE-like sequence, this mutation was
without effect on yHac1 binding. Interestingly, for M1, yHac1 binding
was slightly stronger. This could be due to the fact that the last
mutated base in M1 changed a C residue to A, resulting in more
similarity with the UPRE core sequence ACAGCTTG. As
summarized in Fig. 6B, the most critical yHac1 binding
domain to the CAGC motif spans
148 to
145, which occurs within the
larger YY1 binding site previously mapped by this same set of mutations
to
152 to
141 (16). For YY1 binding to the 78core, M1 and M3
mutation severely diminished YY1 binding, whereas M2 retained weak
binding affinity for YY1 (16). Lastly, in vitro translated
YY1 while exhibiting strong binding to the 78core does not bind the
UPRE (Fig. 6B).

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 6.
Delimitation of the boundary of the yHac1
binding site within the grp78 core. A,
the EMSAs were carried out with 2 µl of in vitro
translated yHac1 and 100,000 cpm of each of the oligomers indicated on
top. B, sequences of the 78core and its mutants
(M1 and M4) as compared with UPRE. Solid boxes highlight the
UPRE or UPRE-like site. The broken boxes indicate the
boundaries of the YY1 binding site previously defined using the same
set of mutant oligomers (16). Italicized, bold
lowercase letters indicate mutated sequences. The ability of each
oligomer to bind yHac1 and YY1 is summarized. +, binding; ++, strong
binding; +/ , partial binding; , no binding.
|
|
Hac1 Stimulation of Specific Mammalian ERSE--
If yHac1
stimulation is dependent on its binding to the grp78
promoter, the prediction is that yHac1 should be able to stimulate the
promoter activity mediated by ERSE-163 contained within the grp78 core sequence but not the C1 element, which does not
contain a UPRE-like sequence and does not bind yHac1 (Fig.
7A). Further, mutation of the
UPRE-like sequence to eliminate specifically yHac1 binding within the
78core should diminish Hac1-mediated stimulation. Because the M2
mutation resulted in the loss of Hac1 binding and reduction in YY1
binding activity (Fig. 6), we created a new 78core mutant M5, which
contains a single base mutation that changes the critical
CAGC sequence to CATC. This mutation resulted
in even stronger binding for YY1 (Fig. 7A), because the CATC
motif corresponds to the consensus YY1 binding site (24). However, the
ability to bind yHac1 was severely diminished for M5 as compared with
the wild-type core (Fig. 7A). For 78C1, although it does not
bind yHac1, YY1 binding can be detected and is mediated by the CCACG
motif (11).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 7.
Sequence-specific induction of ERSEs by
yHac1. A, sequences of 78core, 78core with the M5
mutation, and 78C1 are shown. The ERSE sequences are
bracketed. The partially conserved sequence motifs within
the ERSEs are boxed. In the M5 mutant, a single point
mutation converts the G residue of the 78core CCAGC to T. The ability
of each of the oligomers to bind in vitro translated yHac1
and YY1 are summarized. B, NIH3T3 cells were co-transfected
by the SuperFect method with 4 µg of promoter construct (78coreCAT,
78core(M5)CAT, or 78C1CAT), 2 µg of pMCX-Hac1(230aa), and empty
vector to a final DNA concentration of 10 µg/plate. 1 µg of SV40
-galactosidase was included in the assay to monitor the efficiency
of transfection. The transfected cells were either untreated or treated
with 300 nM Tg. The fold stimulation of the promoter
activities with standard deviations are shown.
|
|
To test the promoter sequence requirements for yHac1
stimulation in vivo, CAT reporter genes 78coreCAT,
78core(M5)CAT, and 78C1CAT containing tandem copies of the synthetic
oligomers shown in Fig. 7A linked to the minimal promoter of
mouse mammary tumor virus were co-transfected with the Hac1 expression
vector or empty vector into NIH3T3 cells. In nonstressed cells,
overexpression of yHac1 was able to stimulate the 78core promoter
activity by about 4-fold (Fig. 7B). For M5, there was
minimal increase of 1.2-fold, and for 78C1, no increase was observed.
In cells treated with Tg, yHac1 further stimulated the overall 78core
promoter activity about 6-fold. For M5, Tg stress induction was lost,
and in the presence of yHac1, only 1.5-fold increase was detected. In
the case of 78C1, its promoter activity increased to about 5-fold in
Tg-treated cells and was not affected by overexpression of yHac1. Thus,
the stimulation of the grp78 promoter activity by yHac1 is
promoter sequence-specific and strictly dependent on the sequence
integrity of the CAGC sequence motif. Further, results from the
78core(M5) mutation shows that YY1 binding is not sufficient to confer
stress inducibility, suggesting the involvement of an as yet
unidentified mammalian factor with CAGC as its critical binding site.
Optimal Hac1 Stimulation of the grp78 Promoter Requires an Intact
YY1 Binding Site Adjacent to the UPRE-like Sequence--
To test
whether yHac1 binding alone is sufficient for its stimulative activity,
mutation M6 was created within the context of the native
grp78 promoter. In M6, the sequence from
144 to
140
containing the 3' half of the UPRE-like sequence within ERSE-163 was
mutated from TTGGT to ACGGA, whereas the critical CAGC sequence motif
was preserved (Fig. 8A).
Consistent with the boundaries previously defined for YY1 binding site
(16), YY1 was not able to bind M6 in EMSA experiments, whereas yHac1
binding was fully retained (Fig. 8B). Thus, through M5 and
M6 mutations of ERSE-163, we discovered that yHac1 binding to the
UPRE-like sequence of the grp78 promoter is primarily
mediated through the CAGC sequence, and YY1 binding requires the
sequence immediately 3' to the CAGC motif. Despite the ability of yHac1
to bind to the promoter sequence bearing the M6 mutation, when the
construct
154(M6)CAT was tested in co-transfection experiments,
yHac1-mediated stimulation of the grp78 promoter was reduced
to half of that observed with the wild-type promoter under both
nonstressed and Tg stressed conditions (Fig. 8C). These
results showed that the YY1 binding site is required for the optimal
stimulation of the rat grp78 promoter by yHac1. Further, it
is noted that in the absence of exogenously expressed yHac1, the
stress-inducibility of
154(M6)CAT was similar to
154CAT. This is
consistent with the functional redundancy of the grp78 promoter because of multiple ERSEs (25).

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 8.
Maximal yHac1 stimulation of the rat
grp78 promoter requires intact YY1 binding site.
A, alignment of the 78core sequence and the 78core(M6)
oligomer bearing mutations as indicated by italicized,
bold lowercase letters in the 3' half-site of YY1 binding
region. The conserved motifs of the ERSE are indicated by the
closed box, and the binding boundaries of YY1 by the
broken box. The ability of the 78core and 78core(M6) to bind
Hac1 and YY1 are summarized. B, EMSA of in vitro
translated yHac1 and YY1 with 78core and 78core(M6) as probe performed
as in Fig. 6A. The position of the Hac1 complex is indicated
by closed arrow, and the YY1 complex is shown by the
open arrow. C, graphic representation of fold
stimulation induced by Hac1 on the grp78 promoter wild-type
construct 154CAT versus the mutant 154(M6)CAT, in
control and Tg stressed cells. 5 µg of each construct were
co-transfected into NIH3T3 cells with an equal amount of
pMCX-Hac1(230aa) or empty vector and an equal amount of SV40
-galactosidase by the calcium phosphate method. The standard
deviations are shown.
|
|
Enhancement of yHac1 Stimulation of the grp78 Core Sequence by
YY1--
The requirement of the YY1 binding site for optimal Hac1
stimulating activity on ERSE-163 suggests that YY1 may be a
co-activator for yHac1. To test this, expression vectors for YY1 and
yHac1 were co-transfected into NIH3T3 cells using either 78coreCAT or 78core(M5)CAT as the reporter genes. Our results confirmed that yHac1
stimulates both basal and Tg-induced promoter activity of the 78core,
whereas YY1 only exerts a stimulative effect under Tg stressed
conditions (Fig. 9A). When
both proteins were overexpressed, the 78core promoter activity was
enhanced over the level achieved by yHac1 alone. The stimulation of
yHac1 activity by YY1, although only in the range of 1.5-2-fold, is
strictly dependent on the sequence integrity of the yHac1 binding
domain CAGC because no stimulation was observed with the M5 mutant that
lost yHac1 binding (Fig. 9B). Further, whereas yHac1
stimulation of the 78core increased with increasing amount of yHac1,
optimal stimulation by YY1 was observed at low dosage, and increasing
the dosage of YY1 beyond the optimal amount resulted in mild
suppression instead (Fig. 9C and data not shown). The
suppressive effect observed with high level expression of YY1 could be
associated with squelching of the transcription machinery (26).
Collectively, these results suggest that yHac1 activity is
rate-limiting, but there may already be a saturating amount of
endogenous YY1 dampening the effect of exogenous YY1. In agreement with
the requirement of the YY1 binding site for optimal yHac1 stimulation
of the rat grp78 promoter (Fig. 8), deletion of the
DNA-binding domain of YY1 resulted in minimal stimulation of the yHac1
activity on the 78core activity (Fig. 9C).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 9.
Co-stimulatory effect of Hac1 and YY1 on the
grp78 core sequence. The co-transfection
experiments were performed in NIH3T3 cells using either the 78coreCAT
(A and C) or 78core(M5)CAT (B) as
reporter genes. 2 µg of Hac1(230aa) and 2 µg of YY1 expression
vectors were used. The transfected cells were either nontreated
(control) or treated with Tg. In C, various amounts of YY1
or the DNA-binding domain defective mutant of YY1 (YY1 ) as indicated
were co-transfected. The fold stimulation of the promoter activities
with the standard deviations are shown.
|
|
 |
DISCUSSION |
The recent discovery of the tripartite structure of the mammalian
ER stress response element ERSE provides important information on the
regulatory components mediating the mammalian UPR (10). Thus, within
the rat grp78 promoter are three ERSEs, named ERSE-98, ERSE-131, and ERSE-163, with highly similar but distinct sequences that
are evolutionarily conserved among promoter elements of ER chaperone
genes. The fact that each ERSE is able to confer ER stress inducibility
to a heterologous promoter (14) suggests that the grp78
promoter contains functionally redundant ERSEs. Our studies reveal
several new findings leading to the proposal of a more complete model
for mammalian stress induction mediated by the ERSE-163 (Fig.
10). Importantly, our model suggests
that despite major differences, some key features of the mammalian UPR
are conserved with the yeast UPR.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 10.
Shared features of ER stress induction of ER
chaperone promoters. The induction for the yeast KAR2
promoter as proposed by Welihinda et al. (31) (A)
is compared with that proposed for the mammalian grp78 gene
(B). Both promoters contain a UPRE or UPRE-like functional
element that has the ability to bind Hac1, a bZIP protein. The Ada
family of proteins serve as adapter proteins between Hac1 and Gcn5 in
S. cerevisiae, whereas YY1 as an interactive partner of p300
and its associating protein PCAF could serve as the bridge protein in
mammalian cells. Both Gcn5 and PCAF possess histone acetylase activity
that could activate transcription through modification of chromatin
structure. There are also unique features of each promoter system. The
yeast promoter contains a heat shock element that is absent from the
rat grp78 promoter, whereas the grp78 promoter
contains two other functional ERSEs downstream of ERSE-163. In
addition, the mammalian ERSE contains a tripartite structure, with the
CCAAT or CCAAT-like motif binding NF-Y/CBF, and the 9-bp region
required for the stress-inducible ERSF binding (10). The model predicts
that a Hac1-like protein yet unidentified in mammalian cells binds to
the UPRE-like sequence within ERSE-163 and, in cooperation with YY1 and
other co-factors, activates grp78 stress induction.
|
|
The yeast promoter contains two simple regulatory sequences, UPRE and
heat shock element, that allow the yeast KAR2 gene to respond to the
accumulation of malfolded proteins in the ER and in the cytoplasm. In
analyzing transcription factors that interact with various ERSEs, we
discovered that ERSE-163 is the only ERSE of the grp78
promoter that shares near sequence identity with the yeast UPRE. We
provide here evidence that yHac1 selectively binds the ERSE-163, and
the binding occurs within the sequence motif GGCCAGCTG, which
distinctively undergoes stress-inducible changes (16). ERSE-163 is also
strongly trans-activated by overexpression of yHac1. Because
other ERSEs such as ERSE-98, although unable to bind Hac1 are
nonetheless strong mediators of the UPR (10, 14, 15), one explanation
is that the organization of the mammalian grp78 promoter has
diverged from the yeast gene to ensure the induction of mammalian UPR
by multiple pathways. Alternatively, the mammalian homolog of yHac1 may
differ from yHac1 such that it is able to interact with all the ERSEs,
which might be regulated through one common mechanism. The resolution
of this awaits the isolation of mammalian Hac1.
Unexpectedly, mutational analysis revealed that the core binding site
required for yHac1 binding on the mammalian grp78 promoter is considerably less stringent than the yeast UPRE. In S. cerevisiae, Hac1 is the only trans-acting factor
demonstrated to bind the UPRE so far, whereas the more complex
mammalian ERSEs have the ability to bind multiple transcription
factors, as the CCAAT binding factor NF-Y, also referred to as CBF (11,
15, 27, 28), YY1 (12, 29), and the recently identified novel
transcription complex termed ERSF (Ref. 10 and data not shown). Another
transcription factor, ATF-6, is a potent activator of the
grp promoters, but its direct binding to ERSE has not been
demonstrated (9). In yeast, Hac1 mRNA is the substrate of the
serine-threonine kinase Ire1p with a dual endoribonuclease function,
and Hac1 expression is uniquely controlled at the level of translation.
Here we showed that mammalian cells are not able to process
yHac1 mRNA to produce the 238-aa form of Hac1 in
response to ER stress. Two mammalian homologs hIre1p(
) and
hIre1p(
) of the yeast IRE1p kinase have been recently identified
(21, 30). The human hIre1p(
) is able to cleave the yHac1
mRNA substrate at the identical 5' splice site as yeast Ire1p but
not at the 3' splice site. So far, ribonuclease activity has not been
demonstrated for hIre1p(
). Thus, the mammalian homolog of yHac1, if
one exists, may have a divergent 3' splice site, or another yet
unidentified homolog of hIre1p with the necessary splicing capability
may be involved. Alternatively, the putative mammalian Hac1-like
activity upon stress induction may be regulated entirely differently
from yHac1. Another divergent feature of Hac1 regulation in yeast and
mammalian cells is that the unspliced form of yHac1 can be translated
and stably expressed in nonstressed mammalian cells. Thus, the
unprecedented translation attenuation mechanism to suppress expression
of Hac1 in nonstressed yeast cells is apparently not conserved in
mammalian cells.
It has been demonstrated that yHac1 acts in concert with co-factors to
activate transcription. In S. cerevisiae, the
transcriptional co-activator complex having histone acetylase activity
composed by Ada2, Ada3, Ada5, and Gcn5 is required for maximal
transcriptional induction of the yeast grp78 promoter (31).
Interaction between Gcn5 and Ire1p is also demonstrated. The direct
association of these co-activator complexes with Ire1p, which is
localized to subcompartments within the ER, with particular
concentration around the nuclear envelope, led to the suggestion that
the nucleoplasmic domain of Ire1p may serve as a nucleation site for
assembly of a multisubunit transcriptional complex (21). Our studies
here demonstrated that one such co-activator of the putative mammalian Hac1 activity as part of the multi-protein complex in mammalian cells
may be YY1. When co-transfected, YY1 enhances the stimulating activity
of yHac1, and this requires the DNA-binding domain of YY1 for full
activity. In support for the requirement of YY1 binding for maximal
Hac1 activity, a selective mutation of the YY1 site adjacent to the
UPRE-like sequence within ERSE-163, which eliminates YY1 binding while
retaining yHac1 binding, results in the inability of Hac1 to
transactivate the promoter at the same magnitude as in the presence of
a functional YY1 binding site. YY1 is able to interact with members of
the ATF/CREB family proteins, which like yHac1 are bZIP proteins (32).
Detailed structure-function analyses in vitro and in
vivo revealed that the interaction is mediated through the
C-terminal zinc finger domain of YY1 and the basic-leucine zipper
region of ATFa2. This study suggests that the C-terminal domain of YY1
is able to interact with yHac1 through its bZIP domain and that YY1
devoid of its C-terminal domain would not be able to stimulate Hac1
activity. In support of this hypothesis, in vitro
glutathione S-transferase pull-down assays confirmed that
YY1 is able to interact with Hac1, and laser confocal microscopy
revealed that transfected yHac1 and YY1 co-localized in the nuclei
(data not shown). Further, enhancement of yHac1 activity by YY1
requires its C-terminal domain, which confirms our previous observation
that stimulation of grp78 promoter by YY1 in stressed
mammalian cells requires its C-terminal domain (12). The lack of
stimulation by the truncated YY1 could be attributed to loss of DNA
binding and/or protein-protein interaction. This issue is now resolved
in part by mutating the core YY1 site from CAG to CAT within the
ERSE-163. This mutation results in even stronger binding of YY1 to the
site because CAT is the core of the YY1 consensus binding site (24).
Strikingly, this mutation resulted in the loss of YY1 stimulation of
the ERSE-163-mediated promoter activity under ER stress induction. This
result showed that YY1 binding alone is not sufficient for its
stimulation effect and further suggests that this mutation could have
disrupted another regulatory factor required for YY1 activity. Indeed,
this one base mutation severely diminishes yHac1 binding, correlating
with the loss of its stimulatory activity. Thus, if YY1 requires
mammalian Hac1 binding to ERSE-163 to act and because the production of mammalian Hac1 is expected to be regulated by ER stress, this could
explain why the constitutively expressed YY1 can stimulate the
grp78 promoter only under ER stress conditions.
The same mutation raises the question of how is it possible that two
co-factors that interact at the protein-protein level and have the same
DNA-binding sequence requirement (CAGC) may co-occupy the site, if
binding of both is a prerequisite. A possible explanation is that when
the complex is formed between yHac1 and YY1, the latter binds the
AC-rich sequence on the noncoding strand immediately 3' to the CAGC
motif. In support, the M2 mutation of the grp78 core, which
has mutated the CAGC sequence but contains intact the adjacent AC-rich
sequence and the rest of the larger YY1 binding site, was able to
compete partially with the wild-type grp78 core for YY1
binding when compared with other mutated sequences (16). Several
properties of YY1 suggest that it could play a role similar to that of
the co-activator complexes that act in concert with Hac1 and Ire1p in
yeast. YY1 and p300/CBF are known to form a physical complex in
vivo and in vitro. Binding assays further mapped the
p300-interacting domain to the C-terminal half of YY1 (33). By
recruiting p300/CBF and its associating factors such as PCAF with
intrinsic histone acetylase activity (34), YY1 binding to ERSE-163
could lead to targeted histone acetylation, resulting in change of
chromatin structure and activation of gene transcription (Fig. 10).
Preliminary analysis suggests that histone acetylation is part of the
regulatory machinery of grp expression in mammalian
cells.2
Despite the strong prediction of the existence of a mammalian Hac1
based on the isolation of yHac1 in 1996, the mammalian homologs of
yeast Ire1p have only been isolated recently. The identification of a
mammalian Hac1 activator protein defined as a direct substrate of the
Ire1p kinase and the ability to bind a UPRE-like sequence in mammalian
chaperone promoters remains elusive. Because of the lack of a genetic
screen in mammalian cells, the isolation of mammalian Hac1, if one
exists, relies on precise definition of its binding site and
transactivating properties on the mammalian ERSE. Here we identified
the boundaries of a unique binding site for yHac1 within ERSE-163 and
have created mutants that can dissect its binding from the overlapping
YY1 binding site. This will greatly facilitate the isolation and
characterization of a mammalian equivalent of yHac1, which will lead to
a direct test of the model proposed for the ER stress induction of
grp78 and other coordinately regulated ER-chaperone gene
promoters in mammalian cells.
 |
ACKNOWLEDGEMENTS |
We thank Peter Baumeister, Xin Wang, and
Trevor Phan for technical assistance and Wilfred Li for helpful discussions.
 |
FOOTNOTES |
*
This work was supported by U. S. Public Health Service
Grant CA27607 from the NCI, National Institutes of Health (to A. S. L.) and Grant 53777 from the NHLBL, National Institutes of
Health (to R. J. K.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom reprint requests should be addressed. Tel.:
323-865-0507; Fax: 323-865-0094; E-mail: amylee@hsc.usc.edu.
2
I. Christadoupoulos and A. S. Lee,
unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
ER, endoplasmic
reticulum;
UPR, unfolded protein response;
aa, amino acid(s);
base
pair(s), UPRE, unfolded protein response element;
HA, hemagglutinin;
PCR, polymerase chain reaction;
CAT, chloramphenicol acetyltransferase;
Tg, thapsigargin;
EMSA, electrophoretic mobility shift assay.
 |
REFERENCES |
| 1.
|
Lee, A. S.
(1987)
Trends Biochem. Sci.
12,
20-23[CrossRef]
|
| 2.
|
Pahl, H. L.,
and Baeuerle, P. A.
(1995)
EMBO J.
14,
2580-2588[Medline]
[Order article via Infotrieve]
|
| 3.
|
McMillan, D. R.,
Gething, M. J.,
and Sambrook, J.
(1994)
Curr. Opin. Biotechnol.
5,
540-545[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Kaufman, R. J.
(1999)
Genes Dev.
13,
1211-1233[Free Full Text]
|
| 5.
|
Cox, J. S.,
and Walter, P.
(1996)
Cell
87,
391-404[CrossRef][Medline]
[Order article via Infotrieve]
|
| 6.
|
Kawahara, T.,
Yanagi, H.,
Yura, T.,
and Mori, K.
(1997)
Mol. Biol. Cell
8,
1845-1862[Abstract/Free Full Text]
|
| 7.
|
Chapman, R. E.,
and Walter, P.
(1998)
Curr. Biol.
7,
850-859
|
| 8.
|
Mori, K.,
Kawahara, T.,
Yoshida, H.,
Yanagi, H.,
and Yura, T.
(1996)
Gene Cells
1,
803-817
|
| 9.
|
Yoshida, H.,
Haze, K.,
Yanagi, H.,
Yura, T.,
and Mori, K.
(1998)
J. Biol. Chem.
273,
33741-33749[Abstract/Free Full Text]
|
| 10.
|
Roy, B.,
and Lee, A. S.
(1999)
Nucleic Acids Res.
27,
1437-1443[Abstract/Free Full Text]
|
| 11.
|
Roy, B.,
Li, W. W.,
and Lee, A. S.
(1996)
J. Biol. Chem.
271,
28995-29002[Abstract/Free Full Text]
|
| 12.
|
Li, W. W.,
Hsiung, Y.,
Zhou, Y.,
Roy, B.,
and Lee, A. S.
(1997)
Mol. Cell. Biol.
17,
54-60[Abstract]
|
| 13.
|
Li, W. W.,
Hsiung, Y.,
Wong, V.,
Galvin, K.,
Zhou, Y.,
Shi, Y.,
and Lee, A. S.
(1997)
Mol. Cell. Biol.
17,
61-68[Abstract]
|
| 14.
|
Li, W. W.,
Alexandre, S.,
Cao, X.,
and Lee, A. S.
(1993)
J. Biol. Chem.
268,
12003-12009[Abstract/Free Full Text]
|
| 15.
|
Zhou, Y.,
and Lee, A. S.
(1998)
J. Natl. Cancer Inst.
90,
381-388[Abstract/Free Full Text]
|
| 16.
|
Li, W. W.,
Sistonen, L.,
Morimoto, R. I.,
and Lee, A. S.
(1994)
Mol. Cell. Biol.
14,
5533-5546[Abstract/Free Full Text]
|
| 17.
|
Liu, E. S.,
and Lee, A. S.
(1991)
Nucleic Acids Res.
19,
5425-5431[Abstract/Free Full Text]
|
| 18.
|
Kaufman, R. J.,
Davies, M. V.,
Wasley, L. C.,
and Michnick, D.
(1991)
Nucleic Acids Res.
19,
4485-4490[Abstract/Free Full Text]
|
| 19.
|
Shi, Y.,
Seto, E.,
Chang, L. S.,
and Shenk, T.
(1991)
Cell
67,
377-388[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Chang, S. C.,
Erwin, A.,
and Lee, A. S.
(1989)
Mol. Cell. Biol.
9,
2153-2162[Abstract/Free Full Text]
|
| 21.
|
Tirasophon, W.,
Welihinda, A. A.,
and Kaufman, R. J.
(1998)
Genes Dev.
12,
1812-1824[Abstract/Free Full Text]
|
| 22.
|
Chen, C. A.,
and Okayama, H.
(1988)
BioTechiques
6,
632-638[Medline]
[Order article via Infotrieve]
|
| 23.
|
Harlow, E.,
and Lane, D.
(1988)
Antibodies: A Laboratory Manual
, pp. 471-506, Cold Spring Harbor Laboratory, Cold Spring Harbor, NY
|
| 24.
|
Yant, S. R.,
Zhu, W.,
Millinoff, D.,
Slightom, J. L.,
Goodman, M.,
and Gumucio, D. L.
(1995)
Nucleic Acids Res.
23,
4353-4362[Abstract/Free Full Text]
|
| 25.
|
Wooden, S. K.,
Li, L. J.,
Navarro, D.,
Qadri, I.,
Pereira, L.,
and Lee, A. S.
(1991)
Mol. Cell. Biol.
11,
5612-5623[Abstract/Free Full Text]
|
| 26.
|
Lee, T.,
Bradley, M. E.,
and Walowitz, J. L.
(1998)
Nucleic Acids Res.
26,
3215-3220[Abstract/Free Full Text]
|
| 27.
|
Ramakrishnan, M.,
Tugizov, S.,
Pereira, L.,
and Lee, A. S.
(1995)
DNA Cell Biol.
14,
373-384[Medline]
[Order article via Infotrieve]
|
| 28.
|
Marcus, N.,
and Green, M.
(1997)
DNA Cell Biol.
16,
1123-1131[Medline]
[Order article via Infotrieve]
|
| 29.
|
Shi, Y.,
Lee, J.-S.,
and Galvin, K. M.
(1997)
Biochim. Biophys. Acta
1332,
49-66
|
| 30.
|
Wang, X. Z.,
Harding, H. P.,
Zhang, Y.,
Jolicoeur, E. M.,
Kuroda, M.,
and Ron, D.
(1998)
EMBO J.
17,
5708-5717[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Welihinda, A. A.,
Tirasophon, W.,
Green, S. R.,
and Kaufman, R. J.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
4289-4294[Abstract/Free Full Text]
|
| 32.
|
Zhou, Q.,
Gedrich, R. W.,
and Engel, D. A.
(1995)
J. Virol.
69,
4323-4330[Abstract]
|
| 33.
|
Lee, J.-S.,
Galvin, K. M.,
See, R. H.,
Eckner, R.,
Livingston, D.,
Moran, E.,
and Shi, Y.
(1995)
Genes Dev.
9,
1188-1198[Abstract/Free Full Text]
|
| 34.
|
Yang, X.-J.,
Ogryzko, V. V.,
Nishikawa, J.-I.,
Howard, B. H.,
and Nakatani, Y.
(1996)
Nature
382,
319-324[CrossRef][Medline]
[Order article via Infotrieve]
|
Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Abdelrahim, K. Newman, K. Vanderlaag, I. Samudio, and S. Safe
3,3'-Diindolylmethane (DIM) and its derivatives induce apoptosis in pancreatic cancer cells through endoplasmic reticulum stress-dependent upregulation of DR5
Carcinogenesis,
April 1, 2006;
27(4):
717 - 728.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Baumeister, S. Luo, W. C. Skarnes, G. Sui, E. Seto, Y. Shi, and A. S. Lee
Endoplasmic Reticulum Stress Induction of the Grp78/BiP Promoter: Activating Mechanisms Mediated by YY1 and Its Interactive Chromatin Modifiers
Mol. Cell. Biol.,
June 1, 2005;
25(11):
4529 - 4540.
[Abstract] |